ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
The following discussion and analysis should be read in conjunction with our unaudited interim condensed consolidated financial statements and related notes thereto as of and
for the three months and nine months ended June 30, 2021, which have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”). Amounts presented in this section are in thousands, except share and
per share data.
As used throughout this Report, “we,” “us”, “our,” “Janel,” “the Company,” “Registrant” and similar words refer to Janel Corporation and its Subsidiaries.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (the “Report”) contains certain statements that are, or may deemed to be, “forward-looking statements” within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934 and that reflect management’s current expectations with respect to our operations, performance, financial condition, and other developments. These forward – looking statements may
generally be identified by the use of the words “may,” “will,” “intends,” “plans,” projects,” “believes,” “should,” “expects,” “predicts,” “anticipates,” “estimates,” and similar expressions or the negative of these terms or other comparable
terminology. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks, uncertainties and assumptions. We caution readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made, and readers are advised that various factors, including, but not limited to, those set forth elsewhere in this Report, could affect our financial performance and could cause our
actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, the impact of the coronavirus on the worldwide economic
conditions and on our businesses, our strategy of expanding our business through acquisitions of other businesses; the risk that we may fail to realize the expected benefits or strategic objectives of any acquisition, or that we spend resources
exploring acquisitions that are not consummated; litigation, indemnification claims and other unforeseen claims and liabilities that may arise from an acquisition; economic and other conditions in the markets in which we operate; the risk that we
may not have sufficient working capital to continue operations; instability in the financial markets; the material weaknesses identified in our internal control over financial reporting; our dependence on key employees; competition from parties who
sell their businesses to us and from professionals who cease working for us; terrorist attacks and other acts of violence or war; security breaches or cybersecurity attacks; competition faced by our global logistics services freight carriers with
greater financial resources and from companies that operate in areas in which we plan to expand; our dependence on the availability of cargo space from third parties; recessions and other economic developments that reduce freight volumes; other
events affecting the volume of international trade and international operations; risks arising from our global logistics services business’ ability to manage staffing needs; competition faced in the freight forwarding, freight brokerage, logistics
and supply chain management industry; industry consolidation and our ability to gain sufficient market presence with respect to our global logistics services business; risks arising from our ability to comply with governmental permit and licensing
requirements or statutory and regulatory requirements; seasonal trends; competition faced by our manufacturing (Indco) business from competitors with greater financial resources; Indco’s dependence on individual purchase orders to generate revenue;
any decrease in the availability, or increase in the cost and supply shortages, of raw materials used by Indco; Indco’s ability to obtain and retain skilled technical personnel; risks associated with product liability claims due to alleged defects
in Indco’s products; risks arising from the environmental, health and safety regulations applicable to Indco; the reliance of our Indco and life sciences businesses on a single location to manufacture their products; the ability of our life
sciences business to compete effectively; the ability of our life sciences business to introduce new products in a timely manner; product or other liabilities associated with the manufacture and sale of new products and services; changes in
governmental regulations applicable to our life sciences business; the ability of our life sciences business to continually produce products that meet high quality standards such as purity, reproducibility and/or absence of cross-reactivity; the
controlling influence exerted by our officers and directors and one of our stockholders; our inability to issue dividends in the foreseeable future; and risks related to ownership of our common stock, including volatility and the lack of a
guaranteed continued public trading market for our common stock. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those projected. You should
not place undue reliance on any of our forward-looking statements which speak only as of the date they are made. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future
events or otherwise. For a more detailed discussion of these factors, see our periodic reports filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K for the fiscal year ended September 30, 2020.
OVERVIEW
Janel Corporation (“Janel,” the “Company” or the “Registrant”) is a holding company with subsidiaries in three business segments: Global Logistics Services, Manufacturing and Life Sciences. The
Company strives to create shareholder value primarily through three strategic priorities: supporting its businesses’ efforts to make investments and to build long-term profits; allocating Janel capital at high risk-adjusted rates of return; and
attracting and retaining exceptional talent.
A management group at the holding company level focuses on significant capital allocation decisions, corporate governance and supporting Janel’s subsidiaries where appropriate. Janel expects to
grow through its subsidiaries’ organic growth and by completing acquisitions. We plan to either acquire businesses within our existing segments or expand our portfolio into new strategic segments. Our acquisition strategy focuses on
reasonably-priced companies with strong and capable management teams, attractive existing business economics and stable and predictable earnings power.
Global Logistics Services
The Company’s Global Logistics Services segment is comprised of several wholly-owned subsidiaries (collectively, “Janel Group”). Janel Group is a non-asset based, full-service provider of cargo
transportation logistics management services, including freight forwarding via air-, ocean- and land-based carriers, customs brokerage services, warehousing and distribution services, and other value-added logistics services.
On December 31, 2020, we completed a business combination whereby we acquired substantially all of the assets and certain liabilities of a global logistics services provider with two U.S.
locations.
On July 23, 2020, the Company acquired a global logistics services provider with two U.S. locations.
Manufacturing
The Company’s Manufacturing segment is comprised of Indco, Inc. (“Indco”). Indco is a majority-owned subsidiary of the Company that manufactures and distributes mixing equipment and apparatus for
specific applications within various industries. Indco’s customer base is comprised of small- to mid-sized businesses as well as other larger customers for which Indco fulfills repetitive production orders.
Life Sciences
The Company’s Life Sciences segment, which is comprised of several wholly-owned subsidiaries, manufactures and distributes high-quality monoclonal and polyclonal antibodies, diagnostic reagents
and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. Our Life Sciences business also produces products for other life science companies on an original equipment
manufacturer (“OEM”) basis.
On December 4, 2020, the Company, through its wholly-owned subsidiary Aves, acquired all of the membership interests of ImmunoChemistry Technologies, LLC.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States. These generally accepted accounting principles
require management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net sales and expenses during the reporting period.
Our senior management has reviewed the critical accounting policies and estimates with the Audit Committee of our Board of Directors. Our significant accounting policies are described in Note 1,
“Summary of Business and Significant Accounting Policies,” in the Notes to our Consolidated Financial Statements for the fiscal year ended September 30, 2020, which are included in our Annual Report on Form 10-K filed with the SEC on January 13,
2021. Critical accounting policies are those that are most important to the portrayal of our financial condition, results of operations and cash flows and require management’s most difficult, subjective and complex judgments, often as a result of
the need to make estimates about the effect of matters that are inherently uncertain. If actual results were to differ significantly from estimates made, the reported results could be materially affected. There were no significant changes to our
critical accounting policies during the nine months ended June 30, 2021.
NON-GAAP FINANCIAL MEASURES
While we prepare our financial statements in accordance with U.S. GAAP, we also utilize and present certain financial measures, in particular adjusted operating income, which is not based on or
included in U.S. GAAP (we refer to these as “non-GAAP financial measures”).
Net Revenue
Net revenue is a non-GAAP measure calculated as total revenue less forwarding expenses attributable to the Company’s Global Logistics Services segment. Our total revenue represents the total
dollar value of services and goods we sell to our customers. Forwarding expenses attributable to the Company’s Global Logistics Services segment refer to purchased transportation and related services including contracted air, ocean, rail, motor
carrier and other costs. Total revenue can be influenced greatly by changes in transportation rates or other items, such as fuel prices, which we do not control. Management believes that providing net revenue and its related margin is useful to
investors as net revenue is the primary indicator of our ability to source, add value and sell services and products that are provided by third parties, and we consider net revenue to be our primary performance measurement. The difference between
the rate billed to our customers (the sell rate) and the rate we pay to the carrier (the buy rate) is termed “net revenue”, “yield” or “margin.” As presented, net revenue matches gross margin.
Organic Growth
Our non-GAAP financial measure of organic growth represents revenue growth excluding revenue from acquisitions within the preceding 12 months. The organic growth presentation provides useful
period-to-period comparison of revenue results as it excludes revenue from acquisitions that would not be included in the comparable prior period.
Adjusted Operating Income
As a result of our acquisition strategy, our net income includes material non-cash charges relating to the amortization of customer-related intangible assets in the ordinary course of business as
well as other intangible assets acquired in our acquisitions. Although these charges may increase as we complete more acquisitions, we believe we will be growing the value of our intangible assets such as customer relationships. Because these
charges are not indicative of our operations, we believe that adjusted operating income is a useful financial measure for investors because it eliminates the effect of these non-cash costs and provides an important metric for our business that is
more representative of the actual results of our operations.
Adjusted operating income (which excludes the non-cash impact of amortization of intangible assets, stock-based compensation and cost recognized on the sale of acquired inventory valuation) is
used by management as a supplemental performance measure to assess our business’s ability to generate cash and economic returns.
Adjusted operating income is a non-GAAP measure of income and does not include the effects of preferred stock dividends, interest and taxes.
We believe that net revenue, organic growth and adjusted operating income provide useful information in understanding and evaluating our operating results in the same manner as management.
However, net revenue, organic growth and adjusted operating income are not financial measures calculated in accordance with U.S. GAAP and should not be considered as a substitute for total revenue, operating income or any other operating
performance measures calculated in accordance with U.S. GAAP. Using these non-GAAP financial measures to analyze our business has material limitations because the calculations are based on the subjective determination of management regarding the
nature and classification of events and circumstances that users of the financial statements may find significant.
In addition, although other companies in our industry may report measures titled net revenue, organic growth, adjusted operating income or similar measures, such non-GAAP financial measures may
be calculated differently from how we calculate our non-GAAP financial measures, which reduces their overall usefulness as comparative measures. Because of these limitations, you should consider net revenue, organic growth and adjusted operating
income alongside other financial performance measures, including total revenue, operating income and our other financial results presented in accordance with U.S. GAAP.
Results of Operations – Janel Corporation
Our results of operations and period-over-period changes are discussed in the following section. The tables and discussion should be read in conjunction with the accompanying Condensed
Consolidated Financial Statements and the notes thereto.
Our consolidated results of operations are as follows:
(in thousands)
|
|
Three Months Ended
June 30,
2021
|
|
|
Three Months Ended
June 30,
2020
|
|
|
Nine Months Ended
June 30,
2021
|
|
|
Nine Months Ended
June 30,
2020
|
|
Revenues
|
|
$
|
34,826
|
|
|
$
|
18,498
|
|
|
$
|
91,446
|
|
|
$
|
57,440
|
|
Forwarding expenses and cost of revenues
|
|
|
26,058
|
|
|
|
13,405
|
|
|
|
68,680
|
|
|
|
40,064
|
|
Gross profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses
|
|
|
7,446
|
|
|
|
5,725
|
|
|
|
20,114
|
|
|
|
18,880
|
|
Operating income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating income (loss)
|
|
$
|
1,868
|
|
|
$
|
(171
|
)
|
|
$
|
4,301
|
|
|
$
|
39
|
|
Consolidated revenues for the three months ended June 30, 2021 were $34,826, or 88.7% higher than for the three months ended June 30, 2020, as a result of increased revenue across all three
segments and the impact of acquisitions, to a smaller extent.
The Company’s net income for the three months ended June 30, 2021 totaled approximately $870 or $0.88 per diluted share, compared to a net loss of ($1,297) or ($1.49) per diluted share for the
three months ended June 30, 2020.
Consolidated revenues for the nine months ended June 30, 2021 were $91,446, or 59.2% higher than for the nine months ended June 30, 2020, as a result of increased revenue across all three
segments and the impact of acquisitions, to a smaller extent.
The Company’s net income for the nine months ended June 30, 2021 totaled approximately $1,721 or $1.75 per diluted share, compared to a net loss of ($2,354) or ($2.71) per diluted share for the
nine months ended June 30, 2020.
The following table sets forth a reconciliation of operating income (loss) to adjusted operating income (loss):
(in thousands)
|
|
Three Months
Ended June 30,
2021
|
|
|
Three Months
Ended June 30,
2020
|
|
|
Nine Months
Ended June 30,
2021
|
|
|
Nine Months
Ended June 30,
2020
|
|
Operating income (loss)
|
|
$
|
1,322
|
|
|
$
|
(632
|
)
|
|
$
|
2,652
|
|
|
$
|
(1,504
|
)
|
Amortization of intangible assets(1)
|
|
|
288
|
|
|
|
243
|
|
|
|
832
|
|
|
|
729
|
|
Stock-based compensation(2)
|
|
|
31
|
|
|
|
68
|
|
|
|
85
|
|
|
|
217
|
|
Cost recognized on sale of acquired inventory (3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted operating income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amortization of intangible assets represents non-cash amortization expense or impairment expense, if any, attributable to acquisition-related intangible assets, including any portion that is allocated to
noncontrolling interests. Management believes that making this adjustment aids in comparing the Company’s operating results with other companies in our industry that have not engaged in acquisitions.
|
(2)
|
The Company eliminates the impact of stock-based compensation because it does not consider such non-cash expenses to be indicative of the Company’s core operating performance. The exclusion of stock-based
compensation expenses also facilitates comparisons of the Company’s underlying operating performance on a period-to-period basis.
|
(3)
|
The Company has excluded the impact of cost on the sale of acquired inventory in connection with acquisitions as such adjustments represent non-cash items, are not consistent in amount and frequency and are
significantly impacted by the timing and size of the Company’s acquisitions.
|
Results of Operations - Global Logistics Services – Three and Nine Months Ended June 30, 2021 and 2020
Our Global Logistics Services business helps its clients move and manage freight efficiently to reduce inventories and to increase supply chain speed and reliability. Key services include customs
entry filing, arrangement of freight forwarding by air, ocean and ground, warehousing, cargo insurance procurement, logistics planning, product repackaging and online shipment tracking.
Global Logistics Services – Selected Financial Information:
|
|
Three Months Ended
June 30,
|
|
|
Nine Months Ended
June 301,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
Revenue
|
|
$
|
29,369
|
|
|
$
|
15,565
|
|
|
$
|
76,002
|
|
|
$
|
46,972
|
|
Forwarding expenses
|
|
|
24,173
|
|
|
|
12,194
|
|
|
|
62,818
|
|
|
|
35,896
|
|
Net revenue
|
|
|
5,196
|
|
|
|
3,371
|
|
|
|
13,184
|
|
|
|
11,076
|
|
Net revenue margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general & administrative
|
|
|
4,523
|
|
|
|
3,429
|
|
|
|
11,640
|
|
|
|
11,019
|
|
Income (loss) from operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Total revenue for the three months ended June 30, 2021 was $29,369, as compared to $15,565 for the three months ended June 30, 2020, an increase of $13,804 or 88.7%. Of the increase in revenue,
89.5% represented growth primarily due to the rise in transportation rates as a result of capacity issues globally and a recovery in business compared with the depressed levels in the prior year period, while two acquisitions accounted for the
remainder of the growth. Total revenue for the nine months ended June 30, 2021 and 2020 was $76,002 and $46,972, respectively, an increase of $29,030 or 61.8%. Of the increase in revenue, 89% represented organic growth primarily due to the rise in
transportation rates due to capacity issues globally and a recovery in business compared with the depressed levels in the prior year period, while two acquisitions accounted for the remainder.
Forwarding Expenses
Forwarding expenses for the three months ended June 30, 2021 increased by $11,979, or 98.2%, to $24,173 as compared to $12,194 for the three months ended June 30, 2020. Forwarding expenses as a
percentage of revenue were 82.3% and 78.3% for the three months ended June 30, 2021 and 2020, respectively. Similar to the revenue increase, the increase in forwarding expenses
and forwarding expense as a percentage of
revenue reflected higher transportation rates
and increased expenses related to acquisitions.
Forwarding expenses for the nine months ended June 30, 2021 increased by $26,922, or 75.0%, to $62,818 as compared to $35,896 for the nine months ended June 30, 2020. Forwarding expenses as a
percentage of revenue were 82.6% and 76.4% for the nine months ended June 30, 2021 and June 30, 2020, respectively. Similar to the revenue increase, the increase in forwarding expenses and forwarding expense as a percentage of revenue reflected
higher transportation rates and increased expenses related to acquisitions.
Net Revenue and Net Revenue Margin
Net revenue for the three months ended June 30, 2021 was $5,196, an increase of $1,825, or 54.1%, as compared to $3,371 for the three months ended June 30, 2020. This increase was mainly the
result of a recovery in business compared with the depressed levels in the prior year period which drove organic growth of 34% as well as increased revenue from two acquisitions, which accounted for the balance of the growth. Net revenue as a
percentage of revenue decreased to 17.7% compared to 21.7% for the prior year period due to the increase in transportation rates versus the prior year period.
Net revenue for the nine months ended June 30, 2021 was $13,184, an increase of $2,108, or 19.0%, as compared to $11,076 for the nine months ended June 30, 2020. This increase was mainly the
result of a recovery in business compared with the depressed levels in the prior year period which drove organic growth of 5% as well as increased revenue from two acquisitions, which accounted for the balance of the growth. Net revenue as a
percentage of revenue decreased to 17.3% compared to 23.6% for the prior year period due to the increase in transportation rates versus the prior year period.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended June 30, 2021 were $4,523, as compared to $3,429 for the three months ended June 30, 2020. This increase of $1,094, or
31.9%, was largely attributed to
additional expenses from businesses acquired versus the prior year period as well as one-time expenses related to a payment to settle a customer dispute and severance for a senior
leadership change. As a percentage of revenue, selling, general and administrative expenses were 15.4% and 22.0% of revenue for the three months ended June 30, 2021 and 2020, respectively.
Selling, general and administrative expenses for the nine months ended June 30, 2021 were $11,640, as compared to $11,019 for the nine months ended June 30, 2020. This increase of $621, or 5.6%,
was largely attributed to additional expenses from businesses acquired versus the prior year period as well as one-time expenses related to a payment to settle a customer dispute and severance for a senior leadership change. As a percentage of
revenue, selling, general and administrative expenses were 15.3% and 23.5% of revenue for the nine months ended June 30, 2021 and 2020, respectively.
Income (loss) from Operations
Income from operations increased to $673 for the three months ended June 30, 2021, as compared to a loss of ($58) for the three months ended June 30, 2020, an increase of $731. Income from
operations increased during the three months ended June 30, 2021 as a result of cost reductions and, to a lesser extent, the contribution from an acquisition versus the prior year period, partially offset by the one-time expenses discussed above.
Operating margin as a percentage of net revenue for the three months ended June 30, 2021 was 13.0% compared to (1.72%) in the prior year period.
Income from operations increased to $1,544 for the nine months ended June 30, 2021, as compared to $57 for the nine months ended June 30, 2020, an increase of $1,487, or 2,608.7%. Income from
operations increased during the nine months ended June 30, 2021 as a result of cost reductions and, to a lesser extent, the contribution from an acquisition versus the prior year period, partially offset by the one-time expense discussed above.
Operating margin as a percentage of net revenue for the nine months ended June 30, 2021 was 11.7% compared to 0.51% in the prior year period.
Results of Operations - Manufacturing – Three and Nine Months Ended June 30, 2021 and 2020
The Company’s Manufacturing segment reflects its majority-owned Indco subsidiary, which manufactures and distributes industrial mixing equipment.
Manufacturing – Selected Financial Information:
|
|
Three Months Ended
June 30,
|
|
|
Nine Months Ended
June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
2,073
|
|
|
$
|
1,605
|
|
|
$
|
6,471
|
|
|
$
|
5,531
|
|
Cost of sales
|
|
|
944
|
|
|
|
752
|
|
|
|
2,985
|
|
|
|
2,505
|
|
Gross profit
|
|
|
1,129
|
|
|
|
853
|
|
|
|
3,486
|
|
|
|
3,026
|
|
Gross profit margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
682
|
|
|
|
482
|
|
|
|
2,007
|
|
|
|
1,865
|
|
Income from Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Total revenue was $2,073 and $1,605 for the three months ended June 30, 2021 and 2020,
respectively, an increase of $468, or 29.2%. Total revenue was $6,471 and
$5,531 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $940, or 17.0%. The revenue increase in both periods reflected a broad increase across the business relative to the COVID-19 related slowdown in the respective
prior year periods.
Cost of Sales
Cost of sales was $944 and $752 for the three months ended June 30, 2021 and 2020, respectively, an increase of $192, or 25.5%. Cost of sales was $2,985 and $2,505 for the nine months ended June
30, 2021 and 2020, respectively, an increase of $480, or 19.2%. The cost of sales increases in both periods was consistent with the revenue increase in both periods and reflected relatively stable product mix.
Gross Profit and Gross Profit Margin
Gross profit was $1,129 and $853 for the three months ended June 30, 2021 and 2020, respectively, an increase of $276, or 32.4%. Gross profit margin for the three months ended June 30, 2021 and
2020 was 54.5% and 53.1%, respectively. Gross profit was $3,486 and $3,026 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $460, or 15.2%. Gross profit margin for the nine months ended June 30, 2021 and 2020 was 53.9%
and 54.7%, respectively. The gross profit in both periods increased proportionately with the increase in revenue of the business as reflected by relatively stable gross profit margins.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $682 and $482 for the three months ended June 30, 2021 and 2020, respectively, an increase of $200 or 41.5%. Expenses rose faster than revenue
due to higher sales and marketing investments during the quarter compared to the prior year period. Selling, general and administrative expenses were $2,007 and $1,865 for the nine months ended June 30, 2021 and 2020, respectively, an increase of
$142 or 7.6%. The relatively stable selling, general and administrative expenses for the nine months ended June 30, 2021 compared to the prior year period reflected cost savings efforts partially offset by investment in sales and marketing efforts.
Income from Operations
Income from operations was $447 for the three months ended June 30, 2021 compared to $371 for the three months ended June 30, 2020, representing a 20.5% increase from the prior year period.
Income from operations was $1,479 for the nine months ended June 30, 2021 compared to $1,161 for the nine months ended June 30, 2020, representing a 27.4% increase from the prior year period. Operating profit increased in both periods as the
business benefited from management’s decision a year ago not to reduce staffing levels which resulted in favorable operating leverage as revenue recovered, partially offset by investment in sales and marketing efforts.
Results of Operations – Life Sciences – Three and Nine Months Ended June 30, 2021 and 2020
The Company’s Life Sciences segment manufactures and distributes high-quality monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and
provides antibody manufacturing for academic and industry research scientists. Our Life Sciences business also produces products for other life science companies on an OEM basis.
Life Sciences – Selected Financial Information:
|
|
Three Months Ended
June 30,
|
|
|
Nine Months Ended
June 30,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
3,384
|
|
|
$
|
1,328
|
|
|
$
|
8,973
|
|
|
$
|
4,937
|
|
Cost of sales
|
|
|
714
|
|
|
|
82
|
|
|
|
2,145
|
|
|
|
1,066
|
|
Cost recognized upon sales of acquired inventory
|
|
|
227
|
|
|
|
377
|
|
|
|
732
|
|
|
|
597
|
|
Gross profit
|
|
|
2,443
|
|
|
|
869
|
|
|
|
6,096
|
|
|
|
3,274
|
|
Gross profit margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative
|
|
|
1,084
|
|
|
|
951
|
|
|
|
3,273
|
|
|
|
3,002
|
|
Income (loss) from Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Total revenue was $3,384 and $1,328 for the three months ended June 30, 2021 and 2020, respectively, an increase of $2,056 or 154.8%. Of the $2,056 increase in revenue, 82.1% represented organic
growth as the Life Sciences business experienced a recovery from the COVID-led slowdown as well as the introduction of new products and services, with an acquisition accounting for the remainder of the increase. Total revenue was $8,973 and $4,937
for the nine months ended June 30, 2021 and 2020, respectively, an increase of $4,036 or 81.7%. Of the $4,036 increase in revenue, 77.7% represented organic growth as the Life Sciences business experienced a recovery from the COVID-led slowdown as
well as the introduction of new products and services, with an acquisition accounting for the remainder of the increase.
Cost of Sales and Cost Recognized Upon Sale of Acquired Inventory
Cost of sales was $714 and $82 for the three months ended June 30, 2021 and 2020, respectively, an increase of $632 or 770.7%, primarily as a result of business growth and, to a smaller degree,
increased expenses from an acquisition. Cost recognized upon sale of acquired inventory was $227 and $377 for the three months ended June 30, 2021 and 2020, respectively, a decrease of $153 or 40.6%, due to some acquired inventory being fully
amortized partially offset by some acquired inventory.
Cost of sales was $2,145 and $1,066 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $1,079 or 101.2%, primarily as a result of business growth. Cost recognized
upon sale of acquired inventory was $732 and $597 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $135 or 22.6%, due to acquired inventory from an acquisition partially offset by some inventory being fully amortized.
Gross Profit and Gross Profit Margin
Gross profit was $2,443 and $869 for the three months ended June 30, 2021 and 2020, respectively, an increase of $1,574 or 181.1%. During the three months ended June 30, 2021 and 2020, the Life
Sciences segment had a gross profit margin of 72.2% and 65.4%, respectively.
Gross profit was $6,096 and $3,274 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $4,036 or 81.7%. During the nine months ended June 30, 2021 and 2020, the Life
Sciences segment had a gross profit margin of 67.9% and 66.3%, respectively. Gross profit margin for both periods increased in line with revenue, including as a result of contributions from an acquisition, with consistent product mix
period-to-period.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $1,084 and $951 for the three months ended June 30, 2021 and 2020, respectively, an increase of $133, or 14.0%. Selling, general and
administrative expenses were $3,273 and $3,002 for the nine months ended June 30, 2021 and 2020, respectively, an increase of $271 or 9.0%. The increased expenses in both periods reflected leverage of fixed costs and increased expenses from an
acquired business relative to the prior year periods.
Income from Operations
Income (loss) from operations for the three months ended June 30, 2021 and 2020 was $1,359 and ($82), an increase of $1,441. Income from operations for the nine months ended June 30, 2021 and
2020 was $2,823 and $272, an increase of $2,551. The growth in both periods reflected strong organic growth, favorable operating leverage and, to a smaller extent, contributions from an acquisition.
Results of Operations – Corporate and other – Three and Nine Months Ended June 30, 2021 and 2020
Below is a reconciliation of income from operating segments to net income (loss) available to common stockholders.
|
|
Three Months Ended
June 30,
|
|
|
Nine Months Ended
June 30,
|
|
(in thousands)
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
Total income from operating segments
|
|
$
|
2,479
|
|
|
$
|
231
|
|
|
$
|
5,846
|
|
|
$
|
1,490
|
|
Administrative expenses
|
|
|
(838
|
)
|
|
|
(514
|
)
|
|
|
(2,277
|
)
|
|
|
(2,048
|
)
|
Amortization expense
|
|
|
(288
|
)
|
|
|
(243
|
)
|
|
|
(832
|
)
|
|
|
(729
|
)
|
Stock-based compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Corporate expenses
|
|
|
(1,157
|
)
|
|
|
(863
|
)
|
|
|
(3,194
|
)
|
|
|
(2,994
|
)
|
Interest expense
|
|
|
(141
|
)
|
|
|
(108
|
)
|
|
|
(418
|
)
|
|
|
(412
|
)
|
Gain on Paycheck Protection Program loan forgiveness
|
|
|
—
|
|
|
|
—
|
|
|
|
135
|
|
|
|
—
|
|
Net income (loss) before taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
|
(311
|
)
|
|
|
(557
|
)
|
|
|
(648
|
)
|
|
|
(438
|
)
|
Net income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock dividends
|
|
|
(197
|
)
|
|
|
(174
|
)
|
|
|
(566
|
)
|
|
|
(500
|
)
|
Net Income (Loss) Available to Common Stockholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Corporate Expenses
Total corporate expenses, which include amortization of intangible assets, stock-based compensation and merger and acquisition expenses, increased by $294, or by 34.1%, to $1,157 for the three
months ended June 30, 2021 as compared to $863 for the three months ended June 30, 2020. The increase was primarily due to higher amortization of intangible asset expense related to acquisitions versus the
prior year period, partially offset by lower professional expenses and stock-based compensation.
Total corporate expenses increased by $200, or by 6.7%, to $3,194 in the nine months ended June 30, 2021 as compared to $2,994 for the nine months ended June 30, 2020.
The increase was primarily due to higher amortization of intangible asset expense related to acquisitions versus the prior year period, partially offset by lower professional expenses and stock-based compensation.
Interest Expense
Interest expense for the consolidated company increased $33, or 30.6%, to $141 for the three months ended June 30, 2021 from $108 for the three months ended June 30, 2020 as a result of a higher debt level due to acquisitions. Interest expense for the consolidated company for the nine months ended June 30, 2021 increased $6, or 1.5%, to $418, comparable to $412 for the nine months ended June
30, 2020.
Income Taxes
On a consolidated basis, the Company recorded an income tax expense of $311 for the three months ended June 30, 2021, as compared to an income tax expense of $557 for the three months ended June
30, 2020. The increase in expense was primarily due to the increase in pretax income. In 2016, a deferred tax asset was established to reflect a net operating loss carryforward, which the Company has begun
using, and is expected to continue to use, through ongoing profitability.
On a consolidated basis, the Company recorded an income tax expense of $648 for the nine months ended June 30, 2021, as compared to an income tax expense of $438 for the nine months ended June
30, 2020. The increase in expense was primarily due to the increase in pretax income. In 2016, a deferred tax asset was established to reflect a net operating loss carryforward, which the Company has begun
using, and is expected to continue to use, through ongoing profitability.
Preferred Stock Dividends
Preferred stock dividends include any dividends accrued but not paid on the Company’s Series C Cumulative Preferred Stock (the “Series C Stock”). For the three months ended June 30, 2021 and
2020, preferred stock dividends were $197 and $174, respectively, representing an increase of $23, or 13.2%. The increase in preferred stock dividends was the result of the increase in dividend rate as of January 1, 2021 to 8% from 7%, partially
offset by a lower number of shares of Series C Stock outstanding. See note 10 to the condensed consolidated financial statements for additional information.
For the nine months ended June 30, 2021 and 2020, preferred stock dividends were $566 and $500, respectively, representing an increase of $66, or 13.2%. The increase in preferred stock dividends
was the result of the increase in dividend rate as of January 1, 2021 to 8% from 7%, partially offset by a lower number of shares of Series C Stock outstanding. See note 10 to the condensed consolidated financial statements for additional
information.
Net Income (Loss)
Net income was $870, or $0.88 per diluted share, for the three months ended June 30, 2021 compared to net loss of ($1,297), or ($1.49) per diluted share, for the three months ended June 30, 2020. The increase was primarily due to higher revenues and gross profit and lower selling, general and administrative expenses across our operating segments.
Net income was $1,721, or $1.75 per diluted share, for the nine months ended June 30, 2021 compared to net loss of ($2,354), or ($2.71) per diluted share, for the nine months ended June 30, 2020. The increase was primarily due to higher revenues and gross profit and lower selling, general and administrative expenses across our operating segments.
Income (Loss) Available to Common Shareholders
Income available to holders of common shares was $673, or $0.68 per diluted share, for the three months ended June 30, 2020 compared to loss available to holders of common shares of ($1,471), or
($1.69) per diluted share, for the three months ended June 30, 2020. The increase in income primarily was due to higher gross profit and lower selling, general and administrative expenses across our operating
segments.
Income available to holders of common shares was $1,155, or $1.17 per diluted share, for the nine months ended June 30, 2020 compared to loss available to holders of common shares of ($2,854), or
($3.29) per diluted share, for the nine months ended June 30, 2020. The increase in income primarily was due to higher gross profit and lower selling, general and administrative expenses across our operating
segments.
LIQUIDITY AND CAPITAL RESOURCES
General
Our ability to satisfy liquidity requirements, including satisfying debt obligations and fund working capital, day-to-day operating expenses and capital expenditures, depends upon future
performance, which is subject to general economic conditions, competition and other factors, some of which are beyond Janel’s control. Our Global Logistics Services segment depends on commercial credit facilities to fund day-to-day operations as
there is a difference between the timing of collection cycles and the timing of payments to vendors.
As a customs broker, our Global Logistics Services segment makes significant cash advances for a select group of our credit-worthy customers. These cash advances are for customer obligations such
as the payment of duties and taxes to customs authorities primarily in the United States. Increases in duty rates could result in increases in the amounts we advance on behalf of our customers. Cash advances are a “pass through” and are not
recorded as a component of revenue and expense. The billings of such advances to customers are accounted for as a direct increase in accounts receivable from the customer and a corresponding increase in accounts payable to governmental customs
authorities. These “pass through” billings can influence our traditional credit collection metrics. For customers that meet certain criteria, we have agreed to extend payment terms beyond our customary terms. Management believes that it has
established effective credit control procedures and has historically experienced relatively insignificant collection problems.
The COVID-19 pandemic has negatively impacted our liquidity and cash flows. As discussed in greater detail in note 9 to the condensed consolidated financial statements, on April 19, 2020, we
entered into a loan agreement with Santander and executed a U.S. Small Business Administration note pursuant to which we borrowed $2,726 from Santander pursuant to the PPP under the Cares Act, Section 7(a)(36) of the Small Business Act in order to
be able to continue to cover our payroll costs, group health care benefits, mortgage payments, rent and utilities. On July 22, 2021, the Company received notification from Santander that the SBA had granted full forgiveness of the Company PPP Loan
on July 20, 2021 in the amount of $2,726 and interest payable in the amount of $34. The duration and magnitude of the pandemic is not reasonably estimable at this point, and if the pandemic persists, our liquidity and capital resources could be
further negatively impacted.
Our subsidiaries depend on commercial credit facilities to fund day-to-day operations as there is a difference between the timing of collection cycles and the timing of payments to vendors.
Generally, we do not make significant capital expenditures. Janel’s cash flow performance for the 2021 fiscal year is not necessarily indicative of future cash flow performance. As of June 30, 2021, the Company’s cash and working capital deficiency
(current assets minus current liabilities) were $2,926 and $11,818, respectively. As of September 30, 2020, the Company’s cash
and working capital deficiency were $3,349 and $10,372, respectively. Compared with the
prior year period, the Company’s cash and cash equivalents decreased $432, or 12.6%, and its working capital deficiency increased $1,446, or 13.9%. The decrease in cash and increase in working capital deficiency was primarily the result of
acquisitions and slower accounts receivables collections.
Cash flows from operating activities
Net cash provided by operating activities for the nine months ended June 30, 2021 and 2020 was $139 and $1,263, respectively. The decrease in cash provided by operations for the nine months ended
June 30, 2021 compared to the prior year period was driven principally by the timing of cash collections for accounts receivables and cash payments on accounts payables at our Global Logistics Services business.
Cash flows from investing activities
Net cash used in investing activities totaled $3,001 for the nine months ended June 30, 2021, versus $403 for nine months ended June 30, 2020. The Company used $2,874 for the acquisition of two
businesses and $127 for the acquisition of property and equipment for the nine months ended June 30, 2021 compared to $115 for final purchase price adjustments related to an acquisition and $288 for the acquisition of property and equipment for the
nine months ended June 30, 2020.
Cash flows from financing activities
Net cash provided by financing activities was $2,439 for the nine months ended June 30, 2021, versus ($344) used in financing activities for the nine months ended June 30, 2020. Net cash provided
by financing activities for the nine months ended June 30, 2021 primarily included funds from our line of credit partially offset by repayments of term loans.
Off-Balance Sheet Arrangements
As of June 30, 2021, we had no off-balance sheet arrangements or obligations.